跳至主要内容
临床试验/CTRI/2016/09/007273
CTRI/2016/09/007273已完成未知

A prospective, randomized, double blind, three-arm, parallel group, placebo controlled clinical Study to evaluate the Efficacy and Safety of Garlixir TM capsules (250 and 500 mg) in hyperlipidemia patients.

Biogen Extracts Pvt Ltd0 个研究点目标入组 78 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patient meeting the requirements of any one of the following parameters:-
  • .Total cholesterol (201-239 mg/dl),
  • .LDL-C (130-159 mg/dl),
  • .Triglycerides (161-230 mg/dl).
  • 2.Patients willing to give a written informed consent along with audio video visual and willing to visit the site for a regular follow up.
  • 3.Patients willing to abide by and comply with the study protocol requirements & restriction
  • BMI (body mass index) 19-30 kg/m2 (42-66 lb/m2)
  • 4.Patient should be non-alcoholic.
  • 5.Patients willing to abstain from usage of any NSAIDs during the study duration
  • 6.Patients willing to abstain from heavy exercise (Jogging, Weight lifting etc.) during the study duration

排除标准

  • 1.Patients with history or presence of
  • .Any clinically significant Respiratory system disorders
  • .Central nervous system disorders
  • .Reproductive system disorders
  • .Gastro intestinal disorders & having problems in swallowing or digesting.
  • .Diabetes (type I or II) or history of gestational diabetes
  • .Heart disease
  • .Active neoplasmâ??s
  • .Renal or liver disease
  • .Hyperthyroidism or Hypothyroidism
  • 2.Patients who are pregnant, lactating or nursing.
  • 3.Patients currently advised or are on lipid lowering medications (known to affect lipid metabolism, platelet function, or antioxidant status)
  • 4.Patients currently advised or are on blood pressure medications.
  • 5.Patient undergoing the following medications
  • .Protease inhibitors (e.g., indinavir, saquinavir), non-nucleoside reverse transcriptase inhibitors (NNRTIs such as nevirapine, efavirenz), isoniazid,
  • .Blood Thinners such as warfarin and heparin
  • .Anti-platelet drugs such as Aspirin & clopidogrel
  • .Calcium channel blockers including diltiazem
  • .Azole antifungals including ketoconazole, Fluconazole etc
  • .Medications with Garlic Supplements.
  • .Patients using oral contraceptives & Steroids.
  • .Patients smoking 20 or more cigarettes per day (Heavy smokers)

研究者

发起方
Biogen Extracts Pvt Ltd

相似试验